EE200100151A - Pulmonary delivery of the active ingredient with dry powder - Google Patents

Pulmonary delivery of the active ingredient with dry powder

Info

Publication number
EE200100151A
EE200100151A EEP200100151A EEP200100151A EE200100151A EE 200100151 A EE200100151 A EE 200100151A EE P200100151 A EEP200100151 A EE P200100151A EE P200100151 A EEP200100151 A EE P200100151A EE 200100151 A EE200100151 A EE 200100151A
Authority
EE
Estonia
Prior art keywords
active ingredient
dry powder
pulmonary delivery
pulmonary
delivery
Prior art date
Application number
EEP200100151A
Other languages
Estonian (et)
Inventor
Clark Andrew
Kuo Mei-Chang
Lalor Cecily
John Aldous Barry
Original Assignee
Inhale Therapeutic Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Systems, Inc. filed Critical Inhale Therapeutic Systems, Inc.
Publication of EE200100151A publication Critical patent/EE200100151A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
EEP200100151A 1998-09-14 1999-09-13 Pulmonary delivery of the active ingredient with dry powder EE200100151A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (1)

Publication Number Publication Date
EE200100151A true EE200100151A (en) 2002-06-17

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100151A EE200100151A (en) 1998-09-14 1999-09-13 Pulmonary delivery of the active ingredient with dry powder

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198593C (en) 1999-06-09 2005-04-27 罗伯特·E·希弗斯 Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2005503425A (en) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション Delivery of drug ester by the prescribed inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CN1671643B (en) 2002-02-25 2013-05-29 扩散药品有限公司 Bipolar trans carotenoid salts and their uses
EP1539246A4 (en) * 2002-07-03 2007-05-16 Brigham & Womens Hospital Central airway administration for systemic delivery of therapeutics
EP1575563B1 (en) * 2002-12-19 2007-02-14 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
KR101781166B1 (en) 2004-04-23 2017-09-22 사이덱스 파마슈티칼스, 인크. A method for producing a powder containing sulfoalkyl ether cyclodextrin and the powder containing the same
EP2540696B1 (en) 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
RU2007137121A (en) * 2005-03-09 2009-04-20 Оно Фармасьютикал Ко., Лтд. (Jp) PARTICLE AND PREPARATION CONTAINING THE SPECIFIED PARTICLE
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
PL2581078T3 (en) 2005-10-26 2015-07-31 Cydex Pharmaceuticals Inc Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
CN101541311B (en) * 2006-10-25 2013-01-23 大日本住友制药株式会社 Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
EP2146948A4 (en) 2007-04-13 2010-08-04 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
CN101878040A (en) 2007-10-31 2010-11-03 扩散药品有限公司 A new class of therapeutics that enhance small molecule diffusion
TR201802619T4 (en) * 2009-05-20 2018-03-21 Aeras Stable, spray-dried, immunogenic, viral compounds.
EP2445339B1 (en) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Diffusion enhancing compound and its use with a thrombolytic
EP2575487B1 (en) 2010-06-02 2017-10-18 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
KR102240042B1 (en) 2012-05-03 2021-04-14 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
DK3212212T3 (en) 2014-10-31 2020-12-21 Univ Monash POWDER FORMULATION
EP3432929A4 (en) 2016-03-24 2019-11-27 Diffusion Pharmaceuticals LLC Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
WO1993025198A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
PT954282E (en) * 1997-01-16 2005-06-30 Massachusetts Inst Technology PREPARATION OF PARTICLES FOR INHALATION
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
TNSN99173A1 (en) 2005-11-10
EA003476B1 (en) 2003-06-26
DZ2892A1 (en) 2003-12-15
UY25711A1 (en) 1999-11-17
SA99200718B1 (en) 2006-11-04
PA8481901A1 (en) 2002-04-25
CO5130023A1 (en) 2002-02-27
IS5878A (en) 2001-03-05
AR022090A1 (en) 2002-09-04
AP1374A (en) 2005-02-28
LT2001021A (en) 2001-11-26
YU24201A (en) 2003-08-29
TR200101182T2 (en) 2001-09-21
CZ2001829A3 (en) 2001-09-12
MY129282A (en) 2007-03-30
CN1317977A (en) 2001-10-17
HUP0103837A3 (en) 2002-11-28
LV12658B (en) 2001-09-20
AP2001002093A0 (en) 2001-03-31
PL195574B1 (en) 2007-10-31
ZA200101995B (en) 2002-03-11
HN1999000159A (en) 1999-11-11
HRP20010189A2 (en) 2005-04-30
LV12658A (en) 2001-05-20
EA200100300A1 (en) 2001-10-22
AU6039799A (en) 2000-04-03
HUP0103837A2 (en) 2002-05-29
AU753014B2 (en) 2002-10-03
MA25590A1 (en) 2002-12-31
GEP20043257B (en) 2004-06-25
CA2343920A1 (en) 2000-03-23
IL141562A (en) 2007-07-24
NZ510168A (en) 2003-09-26
IL141562A0 (en) 2002-03-10
GT199900156A (en) 2001-03-07
EP1117442A1 (en) 2001-07-25
NO20011251L (en) 2001-04-17
NO20011251D0 (en) 2001-03-13
SK3442001A3 (en) 2001-11-06
TWI226248B (en) 2005-01-11
KR20010075063A (en) 2001-08-09
PE20001061A1 (en) 2000-10-08
BG105430A (en) 2001-12-29
HK1042231A1 (en) 2002-08-09
OA11781A (en) 2005-07-26
ID28845A (en) 2001-07-05
JP2002524535A (en) 2002-08-06
LT4897B (en) 2002-02-25
BR9913722A (en) 2001-05-29
PL346768A1 (en) 2002-02-25
WO2000015262A1 (en) 2000-03-23
UA76085C2 (en) 2006-07-17

Similar Documents

Publication Publication Date Title
EE200100151A (en) Pulmonary delivery of the active ingredient with dry powder
DE60035911D1 (en) dry powder inhaler
DE60141579D1 (en) The dry powder inhaler
EE200100212A (en) Aerosol delivery of active ingredient with modulated impedance airflow
DE69918074D1 (en) MAKROLID FORMULATION WITH DELAYED ACTIVE SUBSTANCE
DK1263720T3 (en) Acetidine derivatives, their preparation, and pharmaceutical compositions containing the same
EE04849B1 (en) Substituted phenyl derivatives, their preparation and use
DE69928085D1 (en) DOSAGE FORM WITH EXTENDED ACTIVE SUBSTANCE
HUS1300054I1 (en) Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives and use thereof
IS4364A (en) Dry powder inhalers
EE200100224A (en) Storage-stable active ingredient concentrate with formoterol
HUP0400723A3 (en) Isoxazoline derivatives and herbicide composition comprising the same as active ingredient
EE200000468A (en) The compounds, their use and the pharmaceutical composition
EE200000595A (en) Delivery of the active ingredient to the carrier matrix
LV12624A (en) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
DE69919490D1 (en) POWDER WITH FAT-SOLUBLE ACTIVE SUBSTANCE
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE60001266T2 (en) BETAHISTIN-RELATED FORMULATION WITH CONTROLLED ACTIVE INGREDIENTS
PT1221845E (en) COMBINATIONS OF ACTIVE SUBSTANCES WITH INSECTICIDES AND ACARICIDES CHARACTERISTICS
HUP0104238A2 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
NO20014692D0 (en) 3-amidinobenzenesulfonamide derivatives, medical compositions containing them and intermediates in the preparation thereof
DE60000808D1 (en) Flowable pesticide oil-in-water formulations
ID25972A (en) AEROSOL PESTICIDE FORMULATION

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner